Enhanced Artificial Intelligence Strategies in Renal Oncology: Iterative Optimization and Comparative Analysis of GPT 3.5 Versus 4.0.

Journal: Annals of surgical oncology
Published Date:

Abstract

BACKGROUND: The rise of artificial intelligence (AI) in medicine has revealed the potential of ChatGPT as a pivotal tool in medical diagnosis and treatment. This study assesses the efficacy of ChatGPT versions 3.5 and 4.0 in addressing renal cell carcinoma (RCC) clinical inquiries. Notably, fine-tuning and iterative optimization of the model corrected ChatGPT's limitations in this area.

Authors

  • Rui Liang
    School of Architecture and Urban Planning, Guangdong University of Technology, Guangzhou, Guangdong 510090, China.
  • Anguo Zhao
    Department of Urology, South China Hospital, Medical School, Shenzhen University, Shenzhen, Guangdong, China.
  • Lei Peng
    Department of Urology, The Second Clinical College, North Sichuan Medical College, Nanchong Central Hospital, Nanchong, Sichuan, China.
  • Xiaojian Xu
    Department of Computer Science and Engineering, Washington University in St. Louis, St. Louis, Missouri, USA.
  • Jianye Zhong
    Department of Urology, South China Hospital, Medical School, Shenzhen University, Shenzhen, Guangdong, China.
  • Fan Wu
    Department of Product Design, Dalian Polytechnic University, Dalian 116034, China.
  • Fulin Yi
    North Sichuan Medical College (University), Nanchong, Sichuan, China.
  • Shaohua Zhang
    Agronomy College of Henan Agriculture University/State Key Laboratory of Wheat and Maize Crop Science, Zhengzhou 450046, Henan, China.
  • Song Wu
    National Engineering Research Center for Big Data Technology and System, Services Computing Technology and System Lab, Cluster and Grid Computing Lab, School of Computer Science and Technology, Huazhong University of Science and Technology, Wuhan, China.
  • Jianquan Hou
    1 Department of Urology, First Affiliated Hospital of Soochow University, Suzhou, China.